Breastfeeding Provides Major Protection Against Breast CancerJuly 18, 2002BREASTFEEDING and having large numbers of children are the key to the developing world's low rates of breast cancer compared with Western countries such as Britain, according to landmark research published in The Lancet later this week*. The most extensive study of its kind - led by scientists from Cancer Research UK** - found that the longer women breastfeed, the more they are protected from the disease. This effect is over and above the protection gained from having children. Researchers believe their work is an important step forward in understanding how and why breast cancer develops. If scientists can understand the mechanism, it will help focus research towards developing drugs to replicate the protective effect. Scientists from the charity pooled data from 47 separate studies from 30 different countries, involving 50,000 women with breast cancer and nearly 100,000 women who did not have the disease. They found that for every year that a woman breastfeeds, her risk of breast cancer goes down by 4.3 per cent, on top of the 7 per cent reduction for each child she has. If women breastfed each of their children for an extra six months, it could prevent over 1,000 cases of the disease in Britain each year. Over the time period that women in the study would have been having children, women from the developing world breastfed for an average of about two years per child and averaged around six or seven children. By comparison, the average Western woman breastfed for just two or three months per child and had about two or three children. Lead researcher Professor Valerie Beral, of the Cancer Research UK Epidemiology Unit in Oxford, says: "The results of this study are a major step forward in our understanding of why breast cancer incidence is so high in developed countries. It's long been known that breast cancer is common in situations where women have few children and breastfeed for short periods. We've shown that these factors alone account for much of the high rates of breast cancer in these settings." If British reproductive habits mirrored those of developing countries, it is estimated that women's risk of breast cancer by the age of 70 would fall from 6.3 per 100 women to 2.7 per 100 women. Two thirds of the decrease would be a result of longer breastfeeding and one third because of the increase in number of children. Fellow researcher Dr Gillian Reeves, also of the Cancer Research UK Epidemiology Unit, says: "To expect that substantial reductions in breast cancer incidence could be brought about by women returning to the pattern of childbearing and breastfeeding that typified most societies until a century or so ago is unrealistic. But even if women in the West were to breastfeed each of their children for an extra six months this could prevent five per cent of breast cancers each year." Sir Paul Nurse, Interim Chief Executive of Cancer Research UK, says: "Each piece of evidence we uncover reinforces the view that hormonal and reproductive factors are vital to the development of breast cancer. Extending our knowledge of the disease is likely to bring further advances in the clinic, as well as suggesting strategies for prevention. He adds: "Women need hard evidence in order to make informed choices about their health and it's good that we've been able to provide that." Ends | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes. New mammography technology effective in detecting breast cancer A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. New statistical model could help reduce breast-lesion biopsies A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA). Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||